Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer.

Eun Ju KoEo Jin KimHye Jung ChoJisu OhHan Sung ParkChang Soo RyuJung Oh KimHak Hoon JunSo Young ChongJong Woo KimNam Keun Kim

Published in: Genes & genomics (2022)

The eNOS polymorphisms were not associated with metabolic syndrome prevalence in CRC patients. However, our findings suggest that the eNOS 894G > T polymorphism with MetS was associated with poor clinical outcomes.

Keyphrases

nitric oxide synthase
metabolic syndrome
nitric oxide
endothelial cells
end stage renal disease
newly diagnosed
pi k akt
ejection fraction
insulin resistance
risk factors
cell proliferation
cardiovascular disease
type diabetes
skeletal muscle